Clincosm LogoSign in Get a demo

Surgical Outcome of Vitrectomy for Myopic Traction Maculopathy in Highly Myopic Eyes

Sponsor
Kyorin University (Other)
Overall Status
Completed
CT.gov ID
NCT01658761
Collaborator
(none)
64
Enrollment
1
Location
1
Arm
162
Duration (Months)
0.4
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Surgical outcome of vitrectomy for myopic traction maculopathy in highly myopic eyes was evaluated in each stage. Efficacy of internal limiting membrane was also evaluated whether it may improve visual outcome.

Condition or Disease Intervention/Treatment Phase
  • Procedure: vitrectomy
 N/A

Detailed Description

Surgical outcome of vitrectomy for myopic traction maculopathy in highly myopic eyes was evaluated in each stage of macular retinischisis, foveal detachment, or macular hole. Efficacy of internal limiting membrane was also evaluated whether it may improve visual outcome.

Study Design

Study Type:
Interventional
Actual Enrollment :
64 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
Single (Investigator)
Primary Purpose:
Treatment
Official Title:
Surgical Outcome of Vitrectomy for Myopic Traction Maculopathy in Highly Myopic Eyes
Study Start Date :
Sep 1, 1998
Actual Primary Completion Date :
Feb 1, 2011
Actual Study Completion Date :
Mar 1, 2012

Arms and Interventions

Arm Intervention/Treatment
Experimental: Myopic traction maculopathy

The 71 eyes of 64 patients (14 men and 50 women) with myopic traction maculopathy in highly myopic eyes (refractive errors ≤-8.0 diopters and axial length ≥26.0 mm) who underwent vitrectomy were retrospectively reviewed.

Procedure: vitrectomy
Surgery
Other Names:
  • Myopic traction maculopathy in highly myopic eyes

    		•

    Outcome Measures

    Primary Outcome Measures

    1. Visual acuity [One year]

      Preoperative and postoperative visual acuity

    Secondary Outcome Measures

    1. Optical coherence tomography [One year]

      Anatomical retinal images by optical cohernce tomography

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    30 Years to 90 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Eyes with myopic traction maculopathy in highly myopic eyes with refractive errors ≤ -8.0 diopters and axial length ≥ 26.0 mm who underwent vitrectomy
    Exclusion Criteria:
    • Eyes with follow-up less than a year

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Kyorin Eye Center Mitaka Tokyo Japan 181-8611

    Sponsors and Collaborators

    • Kyorin University

    Investigators

    • Principal Investigator: Makoto Inoue, MD, Kyorin Eye Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Makoto Inoue, Assosiate professor of Ophthalmology, Kyorin University
    ClinicalTrials.gov Identifier:
    NCT01658761
    Other Study ID Numbers:
    • KyorinEye008
    • Myopic maculopathy
    First Posted:
    Aug 7, 2012
    Last Update Posted:
    Aug 7, 2012
    Last Verified:
    Aug 1, 2012
    Keywords provided by Makoto Inoue, Assosiate professor of Ophthalmology, Kyorin University
    Myopic traction maculopathy
    vitrectomy
    internal limiting membrane
    Retrospective, case control study
    Additional relevant MeSH terms:
    Macular Degeneration

    Study Results

    No Results Posted as of Aug 7, 2012